139 related articles for article (PubMed ID: 33565149)
1. The FasLane to ocular pathology-metalloproteinase cleavage of membrane-bound FasL determines FasL function.
Gregory-Ksander M; Marshak-Rothstein A
J Leukoc Biol; 2021 Nov; 110(5):965-977. PubMed ID: 33565149
[TBL] [Abstract][Full Text] [Related]
2. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitis.
Gregory-Ksander M; Perez VL; Marshak-Rothstein A; Ksander BR
Exp Eye Res; 2019 Feb; 179():47-54. PubMed ID: 30365944
[TBL] [Abstract][Full Text] [Related]
4. Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.
Matsumoto H; Murakami Y; Kataoka K; Notomi S; Mantopoulos D; Trichonas G; Miller JW; Gregory MS; Ksander BR; Marshak-Rothstein A; Vavvas DG
Cell Death Dis; 2015 Nov; 6(11):e1986. PubMed ID: 26583327
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.
Audo R; Calmon-Hamaty F; Papon L; Combe B; Morel J; Hahne M
Arthritis Rheumatol; 2014 Dec; 66(12):3289-99. PubMed ID: 25078097
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.
Krishnan A; Fei F; Jones A; Busto P; Marshak-Rothstein A; Ksander BR; Gregory-Ksander M
J Immunol; 2016 Dec; 197(12):4626-4638. PubMed ID: 27849168
[TBL] [Abstract][Full Text] [Related]
8. Role of Fas ligand in ocular tissue.
Sano Y; Sotozono C
Cornea; 2002 Mar; 21(2 Suppl 1):S30-2. PubMed ID: 11995807
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
10. Fas ligand is constitutively secreted by prostate cancer cells in vitro.
Liu QY; Rubin MA; Omene C; Lederman S; Stein CA
Clin Cancer Res; 1998 Jul; 4(7):1803-11. PubMed ID: 9676859
[TBL] [Abstract][Full Text] [Related]
11. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells.
Oyaizu N; Kayagaki N; Yagita H; Pahwa S; Ikawa Y
Biochem Biophys Res Commun; 1997 Sep; 238(2):670-5. PubMed ID: 9299572
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration.
Zhao H; Roychoudhury J; Doggett TA; Apte RS; Ferguson TA
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5321-31. PubMed ID: 23821188
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Bossaller L; Rathinam VA; Bonegio R; Chiang PI; Busto P; Wespiser AR; Caffrey DR; Li QZ; Mohan C; Fitzgerald KA; Latz E; Marshak-Rothstein A
J Immunol; 2013 Sep; 191(5):2104-14. PubMed ID: 23918976
[TBL] [Abstract][Full Text] [Related]
14. IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
Wadsworth SJ; Atsuta R; McIntyre JO; Hackett TL; Singhera GK; Dorscheid DR
J Allergy Clin Immunol; 2010 Aug; 126(2):366-74, 374.e1-8. PubMed ID: 20624652
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.
Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS
J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus.
Lotti R; Shu E; Petrachi T; Marconi A; Palazzo E; Quadri M; Lin A; O'Reilly LA; Pincelli C
Front Immunol; 2018; 9():370. PubMed ID: 29535737
[TBL] [Abstract][Full Text] [Related]
17. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.
Powell WC; Fingleton B; Wilson CL; Boothby M; Matrisian LM
Curr Biol; 1999 Dec 16-30; 9(24):1441-7. PubMed ID: 10607586
[TBL] [Abstract][Full Text] [Related]
18. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.
Song E; Chen J; Ouyang N; Su F; Wang M; Heemann U
Br J Cancer; 2001 Sep; 85(7):1047-54. PubMed ID: 11592778
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand.
Vargo-Gogola T; Crawford HC; Fingleton B; Matrisian LM
Arch Biochem Biophys; 2002 Dec; 408(2):155-61. PubMed ID: 12464266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
